Showing results (521-530 of 779) with videos related to
Sort By:
Pageof 78
JACC. Cardiovascular Interventions|November 24, 2022
Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary InterventionAnoop N Koshy, Gennaro Giustino, Samantha Sartori, et al.The American Journal of Cardiology|December 26, 2007
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowingsJiro Aoki, Ajay J Kirtane, George D Dangas, et al.Heart (British Cardiac Society)|March 21, 2025
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Samantha Sartori, Birgit Vogel, et al.Journal of Cardiology|June 22, 2026
Neutrophil-to-Lymphocyte Ratio in Patients with Low-Flow Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationCarlo Mannina, Esha Vaish, Eric Kim, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 22, 2026
Triglyceride-glucose index as a predictor of adverse cardiovascular outcomes in a contemporary, diverse US population undergoing percutaneous coronary interventionFrancesca Maria Di Muro, Mark Shneyderman, Samantha Sartori, et al.American Heart Journal|November 29, 2016
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyStephan Windecker, Jan Tijssen, Gennaro Giustino, et al.JACC. Cardiovascular Interventions|September 24, 2011
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialAdam J Saltzman, Gregg W Stone, Bimmer E Claessen, et al.JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.The American Journal of Cardiology|January 21, 2022
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina PectorisAnton Camaj, Gennaro Giustino, Nikola Kocovic, et al.International Journal of Cardiology|August 15, 2024
A mobile application for STEMI care optimization: Pilot implementation project reportAnnapoorna S Kini, Haydee Garcia, Bernadette Springer, et al.Pageof 78